NAD+ Booster NMNH Proved for Safety and Efficacy

Overview

NAD-Booster-NMNH-Proved-for-Safety-and-Efficacy.jpg

NMNH, short for Reduced Beta-Nicotinamide Mononucleotide, refers to the reduced form of NMN. Preclinical studies show that NMNH demonstrates a remarkable 10X surge in NAD+ levels.

EffePharm's UthPeak™ NMNH has completed toxicology and efficacy tests, affirming its safety and health potential in the dietary supplement market. Our animal tests highlight its anti-aging, anti-fatigue, and cardiovascular health benefits. Clinical trials on humans are currently underway. Partnering with Double Wood, the first UthPeak™ NMNH product has launched on Amazon. Download the flyer below to learn more.

This content is provided by Effepharm Ltd, and any views and opinions expressed do not necessarily reflect those of NutraIngredients-USA.com

Download Now

Related Topics

Beauty from withinHealthy aging

Latest Content

Uthever NMN, effective solution to UV skin damage

Uthever NMN, effective solution to UV skin damage

Paid for and content provided by Effepharm Ltd

Several independent studies have been conducted to understand the relationship between NMN and aging, and to verify the potency of the anti-aging molecule NMN in reversing skin aging caused by UV radiation.

Related Resources

Your Product Innovation Begins Here: Booth 4055

Your Product Innovation Begins Here: Booth 4055

Content provided by Effepharm Ltd

Product Brochure

EffePharm will showcase innovative anti-aging solutions, featuring UthPeak™, world’s first self-GRAS approved NMNH, which boosts NAD+ levels by 10X. UthPeak™ NMNH can be sold, used, and consumed in the U.S. food supply.

UthPeak™ Reduced NMN Is Now Self-GRAS Approved

UthPeak™ Reduced NMN Is Now Self-GRAS Approved

Content provided by Effepharm Ltd

Product Brochure

UthPeak™ NMNH, marketed as "The Next-Gen Super NAD+ Enhancer," is a patent-pending crystalline NMNH that has demonstrated a remarkable 10X surge in NAD+ levels.

Supplier Info Centre

Effepharm-Ltd.jpg

For more product information visit Effepharm Ltd.